Effects of the APOA5 gene variation on plasma lipids and risk of myocardial inearction in spanish subjects

被引：0
|
作者：
Corella, D
Francesc, F
Sorli, JV
Guillen, M
Carrasco, P
Ordovas, JM
Gimenez, F
Hortoneda, M
Portoles, O
机构：
[1] Univ Valencia, Valencia, Spain
[2] Hosp Clin Univ Valencia, Valencia, Spain
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2005年 / 6卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(05)80089-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [21] Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study
    Lai, CQ
    Demissie, S
    Cupples, LA
    Zhu, YP
    Adiconis, X
    Parnell, LD
    Corella, D
    Ordovas, JM
    JOURNAL OF LIPID RESEARCH, 2004, 45 (11) : 2096 - 2105
  • [22] APOA5 Gene Variation Interacts with Dietary Fat Intake to Modulate Obesity and Circulating Triglycerides in a Mediterranean Population
    Sanchez-Moreno, Carmen
    Ordovas, Jose M.
    Smith, Caren E.
    Baraza, Juan C.
    Lee, Yu-Chi
    Garaulet, Marta
    JOURNAL OF NUTRITION, 2011, 141 (03): : 380 - 385
  • [23] Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges
    Martin, S
    Nicaud, V
    Humphries, SE
    Talmud, PJ
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1637 (03): : 217 - 225
  • [24] Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome
    Niculescu, Loredan S.
    Vladica, Maria
    Sima, Anca V.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 587 - 591
  • [25] Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study
    You, Yueyue
    Wu, Yan-Hua
    Zhang, Yangyu
    Zhang, Lili
    Song, Yan
    Bai, Wei
    Li, Yuanyuan
    Yu, Yaqin
    Kou, Changgui
    BMJ OPEN, 2018, 8 (06):
  • [26] Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene
    Oliva, C. Priore
    Carubbi, F.
    Schaap, F. G.
    Bertolini, S.
    Calandra, S.
    JOURNAL OF INTERNAL MEDICINE, 2008, 263 (04) : 450 - 458
  • [27] Frequency of the polymorphism-1131T > C in apolipoprotein A5 (APOA5) gene in subjects in minas gerais state - brazil
    Gomes, K. B.
    Fernandes, A. P.
    Cruz, N. G.
    Coelho, F. F.
    Santos, I. R.
    Rodrigues, K. F.
    Pinheiro, P. S.
    Guimaraes, D. A.
    Sousa, M. O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 742 - 743
  • [28] A functional polymorphism affecting the APOA5 gene expression is causally associated with plasma triglyceride levels conferring coronary atherosclerosis risk in Han Chinese Population
    Shou, Weihua
    Wang, Ying
    Xie, Fang
    Wang, Beilan
    Yang, Lin
    Wu, Hong
    Wang, Yi
    Wang, Zhimin
    Shi, Jinxiu
    Huang, Wei
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (11): : 2147 - 2154
  • [29] Correlation of APOA5 Gene-1131T>C in The Uighur National Minority in Xinjiang with The Risk of CHD
    Yuan Shan
    Ma Yitong
    CIRCULATION, 2010, 122 (02) : E201 - E201
  • [30] APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease
    Lee, KWJ
    Ayyobi, AF
    Frohlich, JJ
    Hill, JS
    ATHEROSCLEROSIS, 2004, 176 (01) : 165 - 172
12345